![Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study | SpringerLink Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10875-021-01083-7/MediaObjects/10875_2021_1083_Fig3_HTML.png)
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study | SpringerLink
![Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies | Molecular Pharmaceutics Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00919/asset/images/medium/mp2c00919_0004.gif)
Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies | Molecular Pharmaceutics
![Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study - eClinicalMedicine Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/c8e6b454-a244-455a-8ca2-c4c11b672a99/gr1_lrg.jpg)
Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study - eClinicalMedicine
![Antibodies | Free Full-Text | Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines Antibodies | Free Full-Text | Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines](https://www.mdpi.com/antibodies/antibodies-11-00035/article_deploy/html/images/antibodies-11-00035-g001.png)
Antibodies | Free Full-Text | Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors | PLOS ONE
![Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection - ScienceDirect Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121000446-fx1.jpg)
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection - ScienceDirect
![Vaccines | Free Full-Text | Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein Vaccines | Free Full-Text | Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein](https://pub.mdpi-res.com/vaccines/vaccines-11-00963/article_deploy/html/images/vaccines-11-00963-g005.png?1684393702)